WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) — Repligen Corporation RGEN, a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at two upcoming investor conferences. A live webcast of the conference presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and…Read More
Repligen Corporation to Present at Upcoming Investor Conferences Repligen NASDAQRGEN
